Dear Editor, Anaplastic large cell lymphoma (ALCL) is a rare T-cell non-Hodgkin lymphoma with distinct pathologic features characterized by CD30 expressing large pleomorphic lymphoid cells with or without anaplastic lymphoma kinase (ALK) gene rearrangement. The disease commonly spreads to bone marrow, skin, lung, liver, and, rarely, other sites [1]. ALCL rarely occurs in the central nervous system (CNS), of which most are primary ALCL reported in pediatric or immunocompromised patients [2]. ALCL with secondary CNS involvement is extremely rare [3]. Here, we present two adult patients having ALCL with secondary CNS involvement, both treated with standard chemotherapy and autologous hematopoietic stem cell transplant (auto-SCT), and both patients had a relatively long survival. To date, only three other similar cases have been reported and all had much shorter survival with no auto-SCT treatment. A 27-year-old man who presented with a mediastinal mass and general lymphoadenopathy was subsequently diagnosed with ALK-positive ALCL. The tumor cells expressed CD30 and ALK. He received cyclophosphamide, hydroxydaunorubicin (doxorubicin), Oncovin (vincristine), and prednisone/prednisolone (CHOP) chemotherapy along with prophylactic high-dose intrathecal methotrexate for three cycles. One year after the initial diagnosis of ALCL, the patient developed seizures. Contrast-enhanced brain MRI revealed diffuse edema in both the parietal and occipital regions. There was also evidence of parenchymal disease both above and below the tentorium in addition to diffuse pial enhancement and dural involvement (Fig. 1a and b). Cerebrospinal fluid (CSF) cytospin examination revealed a population of large anaplastic lymphoid cells in the background of few granulocytes and macrophages. Flow cytometry of the CSF identified abnormal T cells expressing CD30 and CD4 with loss of other pan-T-cell markers (CD3, CD5, and CD7). A T-cell gene rearrangement analysis of the CSF DNA sample detected a prominent but dim T-cell receptor gamma monoclonal peak. No circulating lymphoma cells were identified in the peripheral blood at that time point. The patient received intrathecal methotrexate and cytarabine followed by wholebrain radiation. His disease was well controlled although it was complicated with severe encephalopathy and cerebral infarct, which caused peripheral vision loss. Five years later, he developed severe abdominal pain and diarrhea. PET/CT scan revealed hypermetabolic activity in the distal duodenum, and biopsy was consistent with recurrent ALCL X. Zhang Department of Pathology and Cell Biology, University of South Florida College of Medicine, Tampa, FL, USA